Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both
the medical and scientific community for the development of novel vaccines and a greater …

With COVID‐19 still hovering around and threatening the lives of many at‐risk patients, an
effective, quick, and inexpensive prognostic method is required. Few studies have shown …

Background COVID 19 was first observed in December 2019 and has affected the world
entire. Effective laboratory markers and prognostic indicators are needed to predict the …

Objective The persistent spread of SARS-CoV-2 makes diagnosis challenging because
COVID-19 symptoms are hard to differentiate from those of other respiratory illnesses. The …

Background. Early identification of patients with severe coronavirus disease (COVID‐19) at
an increased risk of progression may promote more individualized treatment schemes and …

Background COVID 19 was first observed in December 2019 and has affected the world
entire. Effective laboratory markers and prognostic indicators are needed to predict the …

C‑reactive protein (CRP) and albumin are inflammation sensitive parameters that are
regulated by interleukin‑6 inflammatory pathways. The CRP to albumin ratio (CAR) …

Hypertension is one of the main morbidity and mortality risk factors in patients with
coronavirus disease 2019 (COVID-19). We investigated the association between the C …

Introduction: There is paucity of data regarding C reactive protein/Albumin (CRP/Alb) ratio in
patients with SARS-CoV-2 infection. We aimed to evaluate the significance of CRP/Alb ratio …

Objectives The aim of this study was to investigate the relationship between the C-reactive
protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. Methods It was …